Alzheimer's Disease Diagnostics and Therapeutics Market Revenues to Reach USD 9.31 billion by 2028 - Market Size, Share, Forecasts, & Trends Analysis Report by Mordor Intelligence
08 août 2023 09h30 HE
|
Mordor Intelligence
Hyderabad, Aug. 08, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled "Alzheimer's Disease Diagnostics and Therapeutics Market Report (2023-2028)," the market is estimated at...
Global High Potency APIs Market to Reach $41.4 Billion by 2031: Allied Market Research
25 nov. 2022 05h17 HE
|
Allied Market Research
Portland, OR, Nov. 25, 2022 (GLOBE NEWSWIRE) -- A new business intelligence report released by Allied Market Research, the global High Potency APIs Market generated $19.7 billion in 2021, and is...
Rheumatic Fever Treatment Market is estimated with a CAGR of 5.2% during the forecast period - by PMI
11 juin 2021 10h35 HE
|
PMI
Covina, CA, June 11, 2021 (GLOBE NEWSWIRE) -- Rheumatic Fever Treatment Market is estimated with a CAGR of 5.2% during the forecast period. Rheumatic fever is an infectious inflammatory condition...
Global Cancer CDK Inhibitor Market 2019-2029 - Pipeline Analysis is estimated to be US$ 16.1 billion by 2030 with a CAGR of 10.4% during the forecast period - by PMI
17 mars 2021 11h35 HE
|
PMI
Covina CA, March 17, 2021 (GLOBE NEWSWIRE) -- The Global Cancer CDK Inhibitor Market accounted for US$ 6.0 billion in 2019 and is estimated to be US$ 16.1 billion by 2029 and is anticipated to...
Global Schizophrenia Drug Market is estimated to be US$ 9.8 Bn by 2030 with a CAGR of 2.7% during the forecast period - by PMI
24 févr. 2021 10h05 HE
|
PMI
Covina CA, Feb. 24, 2021 (GLOBE NEWSWIRE) -- The global schizophrenia drug market accounted for US$ 7.5 Bn in 2020 and is estimated to be US$ 9.8 Bn by 2030 and is anticipated to register a CAGR of...
Juva Life Advances Intellectual Property Protection Program and Advises on DTC Eligibility
27 janv. 2021 04h30 HE
|
Juva Life Inc.
VANCOUVER, British Columbia, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a California based life sciences...
Coast 2 Coast 4 Cancer Riders Raise Nearly $730,000 to Help Achieve Victory Over Cancer®
15 oct. 2019 09h00 HE
|
The V Foundation for Cancer Research
CARY, NC, Oct. 15, 2019 (GLOBE NEWSWIRE) -- The V Foundation for Cancer Research, a top-rated cancer research charity, is excited to announce that Bristol-Myers Squibb’s 2019 Coast 2 Coast 4 Cancer...
Advantagene Announces Clinical Trial Collaboration
27 avr. 2018 07h00 HE
|
Advantagene, Inc.
AUBURNDALE, Mass., April 27, 2018 (GLOBE NEWSWIRE) -- Advantagene, Inc. today announced that the company entered into a clinical trial collaboration with Bristol-Myers Squibb (NYSE:BMY) to evaluate...
Nsav Announces Major Upgrade of Shanghai Vital Strategic Medical Website and Significant Progress of Mjcoin
06 oct. 2017 14h04 HE
|
NSAV Holding, Inc.
CRESCO, PA, Oct. 06, 2017 (GLOBE NEWSWIRE) -- Net Savings Link, Inc. (OTC: NSAV), announced today that the Company has completed a major upgrade of its Chinese medical website (...
R-PHARM Acquires IXEMPRA(R) (ixabepilone) From Bristol-Myers Squibb and Launches U.S. Commercial Operations
17 août 2015 08h30 HE
|
R-PHARM US, LLC
PRINCETON, N.J., Aug. 17, 2015 (GLOBE NEWSWIRE) -- R-PHARM US announces the acquisition of IXEMPRA (ixabepilone) from Bristol-Myers Squibb (NYSE:BMY). IXEMPRA received marketing approval from the U.S....